Human In Vitro Models of Epilepsy Using Embryonic and Induced Pluripotent Stem Cells


The challenges in making animal models of complex human epilepsy phenotypes with varied aetiology highlights the need to develop alternative disease models that can address the limitations of animal models by effectively recapitulating human pathophysiology. The advances in stem cell technology provide an opportunity to use human iPSCs to make disease-in-a-dish models. The focus of this review is to report the current information and progress in the generation of epileptic patient-specific iPSCs lines, isogenic control cell lines, and neuronal models. These in vitro models can be used to study the underlying pathological mechanisms of epilepsies, anti-seizure medication resistance, and can also be used for drug testing and drug screening with their isogenic control cell lines.

Authors Javaid MS, Tan T, Dvir N, Anderson A, J O'Brien T, Kwan P, Antonic-Baker A
Journal Cells
Publication Date 2022 Dec 7;11(24)
PubMed 36552721
PubMed Central PMC9776452
DOI 10.3390/cells11243957

Research Projects

Cell Lines